glp 1 life extension Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end 1 support supplement designed to support metabolism Body-wide multi-omic counteraction of aging
Description
it may be cellular

Medicines that may interact with Wegovy include: Insulin and some diabetes medicines Taking Wegovy with insulin or medicines that increase insulin levels, such as sulfonylureas, may increase the risk of low blood sugar (hypoglycaemia)

2023 Dec 14;389(24):222132

Exenatide treatment exerts anxiolytic- and antidepressant-like effects and reverses neuropathy in a mouse model of type-2 diabetes

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Ohman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF, EXSCEL Study Group

GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity
